KERRY CIPRIANI: Open Payments
NPI 1790018042 · FARMINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 14 payments from 5 companies in 2025. Trend: 2023 $113 · 2024 $177 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 6 | $239 |
| Novo Nordisk Inc | 3 | $161 |
| PFIZER INC. | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: CARDIOMEMS, Wegovy, VYNDAQEL, LEQVIO, ASSURITY, Kerendia.
Industry payments across CT — which companies pay providers there.
